Kyntra Bio, Inc. KYNB
Set alert
4.57 USD -0.08 -1.72%
At close · Oct 30
4.85 +0.28 +6.13%
After hours · Oct 30, 4:05 PM ET
4.48 Day range 4.70
4.50 52-week range 11.12
- YTD
- -47.95%
- 1 year
- -58.61%
- Open
- 4.52
- Prev close
- 4.65
- Mkt cap
- 18.50M
- Vol
- 24.42K
- Avg vol
- 21.37K
- EPS
- -7.64
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.48
- High
- 4.70
5D chart
Signals (69)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 30, 10:45 AM | 1 day ago |
| MACD: Sell Signal | Oct 30, 10:40 AM | 1 day ago |
| SMA: Bearish | Oct 30, 10:15 AM | 1 day ago |
| MACD: Buy Signal | Oct 30, 10:00 AM | 1 day ago |
| SMA: Bullish | Oct 30, 9:55 AM | 1 day ago |
| SMA: Bullish | Oct 30, 9:55 AM | 1 day ago |
| MACD: Sell Signal | Oct 30, 9:50 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:45 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:45 AM | 1 day ago |
| RSI: Overbought | Oct 29, 3:55 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:50 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:50 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 2:50 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 2:10 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 1:45 PM | 2 days ago |
| RSI: Oversold | Oct 29, 12:35 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:10 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:10 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 12:10 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 11:55 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:50 AM | 2 days ago |
| RSI: Overbought | Oct 29, 11:50 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 11:15 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 10:20 AM | 2 days ago |
| RSI: Overbought | Oct 29, 10:20 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 10:15 AM | 2 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:30 PM | 3 days ago |
| RSI: Overbought | Oct 28, 3:30 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:10 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:10 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:50 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:50 PM | 3 days ago |
| RSI: Overbought | Oct 28, 2:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 1:20 PM | 3 days ago |
| RSI: Overbought | Oct 28, 11:50 AM | 3 days ago |
| SMA: Bullish | Oct 28, 11:45 AM | 3 days ago |
| SMA: Bullish | Oct 28, 11:45 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 11:45 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 11:40 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 11:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 11:05 AM | 3 days ago |
| RSI: Oversold | Oct 28, 11:00 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 10:40 AM | 3 days ago |
| RSI: Oversold | Oct 28, 9:35 AM | 3 days ago |
| RSI: Oversold | Oct 27, 3:50 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:35 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 2:55 PM | 4 days ago |
| RSI: Overbought | Oct 27, 2:05 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 12:15 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 10:00 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:45 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 9:30 AM | 4 days ago |
| RSI: Overbought | Oct 27, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 5 days ago |
| RSI: Oversold | Oct 26, 3:50 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:40 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:40 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 3:40 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 3:25 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 3:15 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:10 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:25 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:25 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:15 PM | 5 days ago |
Financials — quick view
KYNB Revenue — quarterly -1.47M
KYNB Net income — quarterly 11.97M
KYNB EPS — quarterly 2.96
News
- Maxim Group Initiates Coverage On Kyntra Bio with Buy Rating, Announces Price Target of $35
- Lake Street Initiates Coverage On Kyntra Bio with Buy Rating, Announces Price Target of $41
- HC Wainwright & Co. Reiterates Buy on Kyntra Bio, Maintains $43 Price Target
- Kyntra Bio To Reduce The Maximum Aggregate Payments Under Its Royalty Financing Agreement From $125M To $65M; Co. Accelerated Payment Of $42.6M Upfront, Bringing Total Payments Made To Date To $50M; Remaining Payments, Capped At $15M, To Be Paid From 50% Of The Revenue Received From Astellas In The Astellas Territories Excluding Japan
- UPDATE: Kyntra Bio Q2 Adj. EPS $(4.68) Misses $(3.18) Estimate, Sales $(1.474M) Miss $2.007M Estimate
- Kyntra Bio Q2 2026 Earnings Call: Complete Transcript
- This Performance Food Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
- Oppenheimer Initiates Coverage On Kyntra Bio with Outperform Rating, Announces Price Target of $35
- Kyntra Bio Presents New Data For Roxadustat Showing Improvements In Transfusion Independence Regardless Of Ring Sideroblast Status In Anemia Patients
- Rodman & Renshaw Initiates Coverage On Kyntra Bio with Buy Rating, Announces Price Target of $30
Your note
Sign in to keep a note on KYNB — it syncs with the Stock Master app.